Immune · Immune peptide (research)
Thymosin Alpha-1
- Drug class
- Immune peptide (research)
- Status
- Compounded (503A)
- Reviewed
- 2026-06-01 · Dr. Ana Lisa Carr, MD
What Thymosin Alpha-1 is studied for
- Immune modulation (research)
- T-cell function (research)
- Recovery from illness (research)
Mechanism of action
Thymosin Alpha-1 is being studied in the immune category. Immune modulation and T-cell support. Mechanism of action varies by study model; refer to the kindr clinical library for a deeper writeup.
Frequently asked questions
What is Thymosin Alpha-1?
Thymosin Alpha-1 is a immune peptide. Immune modulation and T-cell support.
What is Thymosin Alpha-1 studied for?
Published research has examined Thymosin Alpha-1 for immune modulation, t-cell function, recovery from illness. Human clinical evidence varies by indication.
Is Thymosin Alpha-1 FDA-approved?
No. Thymosin Alpha-1 is not FDA-approved for the indications listed. It is available compounded by 503A pharmacies under clinician supervision, or for international research use only on this catalog.
How is Thymosin Alpha-1 used in research?
Protocols vary by study. Thymosin Alpha-1 is typically administered subcutaneously in research settings. No validated human therapeutic dose exists outside FDA-approved indications.
What are the known risks?
Long-term human safety data for Thymosin Alpha-1 is limited. Theoretical risks vary by mechanism. Any human use should be supervised by a licensed clinician.